XML 108 R81.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
RECEIVABLES (Details)
$ in Millions
12 Months Ended
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Accounts Receivable, after Allowance for Credit Loss [Abstract]      
Trade receivables $ 6,888 $ 4,914  
Less charge-backs and cash discounts (391) (245)  
Less allowances (21) (33)  
Net trade receivables 6,476 4,636  
Alliance, Royalties, VAT and other 1,209 1,111  
Receivables 7,685 5,747  
Receivables sold on a nonrecourse basis $ 797 $ 756 $ 637
The number of the largest pharmaceutical wholesalers in the U.S. 3    
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]      
Document Period End Date Dec. 31, 2019    
Customer Concentration Risk [Member]      
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]      
Percentage Of Aggregate Total Trade Receivables Due 50.00% 70.00%